The Beatty group applies novel chemical tools and technologies towards illuminating human diseases.  When Dr. Beatty started her group at OHSU in 2012, she decided that her focus would be on using innovative and creative approaches to identify and investigate the molecular basis of human diseases, including tuberculosis (TB) and breast cancer.  Research in the Beatty group is collaborative and interdisciplinary.  Her team works on the following projects: 

1.1  Chemical tools for detecting hydrolase activities in Mycobacterium tuberculosis (Mtb).

1.2  Illuminating drug susceptibility in Mtb.

1.3  A new technology for tracking and mapping proteins by light and electron microscopy.

1.4  Identifying molecular interactions that confer drug resistance in breast cancer.

1.5  Synthesis of new fluorescent and fluorogenic probes.

Before joining the faculty at OHSU, Dr. Beatty earned her PhD in chemistry with Professor David Tirrell at Caltech. She completed her postdoc training at UC Berkeley with Professor Carolyn Bertozzi.